Home/Altagenics/Daniel Gordon

DG

Daniel Gordon

Managing Director of GLD Partners LP (Founding Investor)

Therapeutic Areas

Musculoskeletal Geriatrics Oncology Supportive Care Metabolic Disorders

Altagenics Pipeline

Drug	Indication	Phase
Discovery Program (Unnamed)	Sarcopenia (age-related muscle wasting)	Discovery

Leadership Team at Altagenics

Dr. Martin Schiller

CEO of Heligenics (Technology Partner)

Media Contact (River North Agency for GLD Partners)

View full Altagenics profile